Here are the top health news for the day:
Presence of Carcinogen Benzene: Dove, other Unilever Shampoos recalled
Unilever has recalled popular brands of aerosol dry shampoo, including Dove, after discovering they were contaminated with a chemical called benzene that can cause cancer.
The recall also covers brands such as Nexxus, Suave, Tresemmé and Tigi, which makes Rockaholic and Bed Head dry shampoos, according to a notice posted on the Food and Drug Administration's website Friday.
Unilever's recall pertains to products made prior to October 2021. The move once again raises questions about the safety of aerosols in personal-care products. In the past year and a half, a number of aerosol sunscreens have been pulled from shelves, such as Johnson & Johnson's Neutrogena, Edgewell Personal Care Co.'s Banana Boat and Beiersdorf AG's Coppertone along with spray-on antiperspirants like Procter & Gamble Co.'s Secret and Old Spice and Unilever's Suave.
For more details, check out the link given below:
Presence Of Carcinogen Benzene: Dove, Other Unilever Shampoos Recalled
SC denies allowing backdoor entry, cancels MDS admissions granted to seven students
The Supreme Court recently cancelled the admissions granted to seven Postgraduate Dental Students who had been admitted by the concerned dental colleges by backdoor entry, outside the state counselling process.
Upholding the cancellation order issued by the Directorate of Medical Education, Raipur Chhattisgarh, the top court bench comprising of M.R.Shah and M.M. Sundresh denied allowing the students to complete their courses and observed, "the undue sympathy would lead to perpetuating the illegality and giving premium to the students who got admissions illegally."
For more details, check out the link given below:
SC Denies Allowing Backdoor Entry, Cancels MDS Admissions Granted To Seven Students
Rs 30 lakh bond penalty too much, says Supreme Court on NEET PG candidate's plea, seeks NMC response
The Supreme Court recently observed that asking a student to pay Rs 30 lakh penalty against "seat leaving bond" is too much when the yearly fees for the government medical college seat is Rs 1,24,000.
Therefore, inviting the opinions of the National Medical Commission (NMC) in this matter, the top court bench comprising of Justices D.Y.Chandrachud and Hima Kohli has now impleaded the Apex medical commission in this regard.
The court was considering a plea filed by a Junior resident doctor from Madhya Pradesh. It was the grievance of the petitioner doctor Sheeba Rao that his institute Shyam Shah Medical College was asking him to pay Rs 30 lakh seat leaving bond in order to get permission to appear in the National Eligibility-cum-Entrance Test Postgraduate (NEET-PG) Counselling this year.
"It is reasonable for having a higher bond amount to compensate for the loss of seat. But ₹30 lakh is too much," observed the bench while issuing notice in this regard.
For more details, check out the link given below:
Rs 30 Lakh Bond Penalty Too Much, Says Supreme Court On NEET PG Candidate's Plea, Seeks NMC Response
No need of prescription from doctors for refresh tears: DTAB
Granting drug maker Allergan India request to change the category of "Refresh Tears" from prescription drug to over the counter drug, the Drug Technical Advisory Board (DTAB) has agreed to remove the requirement of a prescription from a Registered Medical Practitioner (RMP) in respect of drug product "Refresh Tears" (Carboxymethylcellulose Sodium eye drops IP 0.5% w/v) for its retail sale.
The recommendation was made after considering the proposal made by Allergan India to remove the requirement for a prescription in respect of drug product "Refresh Tears" (Carboxymethylcellulose Sodium eye drops IP 0.5% w/v) sterile opthalmic solution for retail sale.
The drug maker, Allergen, has submitted that its product "Refresh Tears" contains Carboxymethylcellulose Sodium eye drops 0.5% w/v, sterile ophthalmic solution, indicated for the temporary relief of burning, irritation, and discomfort due to dryness of the eyes or exposure to wind or sun, and may be used as a protectant against further irritation, and stated that the product has been marketed since 1998.
For more details, check out the link given below:
No Need Of Prescription From Doctors For Refresh Tears: DTAB
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.